DIANORM M OD 1000 (Gliclazide (60mg) + Metformin (1000mg))

DiaNORM-M OD 1000 Tablet SR is categorized as an anti-diabetic medication. It combines two active substances designed for the management of type 2 diabetes mellitus in adults. This treatment assists in maintaining appropriate blood glucose levels for individuals diagnosed with diabetes. It is crucial to take DiaNORM-M OD 1000 Tablet SR with meals to enhance its effectiveness. Patients are encouraged to take it consistently at the same time each day for optimal results. The prescribing physician will determine the most suitable dosage, which may be adjusted as needed based on individual blood sugar readings. It is essential to continue using this medication, even when feeling well or if blood sugar levels appear stable. Discontinuing use without medical consultation can lead to increased blood sugar levels, elevating the risk for serious complications such as kidney damage, vision loss, nerve issues, and potential amputation. This medication is only one aspect of a comprehensive treatment plan that should also include a nutritious diet, regular physical activity, and weight management as directed by a healthcare professional. Lifestyle choices significantly impact the management of diabetes. Common adverse effects may include low blood sugar (hypoglycemia), constipation, and nausea. Patients must recognize symptoms of hypoglycemia, such as excessive sweating, dizziness, headaches, and tremors, and be prepared to manage these occurrences. Maintaining regular meal schedules and having quick sources of glucose, like sugary snacks or juice, readily available is crucial. Alcohol consumption should be avoided as it can heighten the risk of low blood sugar levels. Other possible side effects may include altered taste sensation, stomach discomfort, diarrhea, headaches, and respiratory infections. Some individuals may experience weight gain while on this medication. It is contraindicated for patients with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic impairment. Prior to starting this therapy, individuals should inform their healthcare provider of any history of heart conditions, as this may impact treatment appropriateness. Regular monitoring of blood glucose levels is advised, and healthcare providers may recommend blood tests to assess blood cell counts and liver function during treatment.